Fosciclopirox

Fosciclopirox Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Zhejiang Huida Biotech Co., LTD  
Tel: 0571-89903022 18679456698
Email: zilong@hizyme.com

Fosciclopirox manufacturers

  • Fosciclopirox
  • Fosciclopirox pictures
  • $48.00
  • 2026-08-03
  • CAS:1380539-06-9
  • Purity: 99.65%
  • Supply Ability: 10g
Fosciclopirox Basic information
Product Name:Fosciclopirox
Synonyms:Fosciclopirox;CPX-POM;γ-secretase,Fosciclopirox,Gamma secretase,Inhibitor,inhibit;2(1H)-Pyridinone, 6-cyclohexyl-4-methyl-1-[(phosphonooxy)methoxy]-;((6-Cyclohexyl-4-methyl-2-oxopyridin-1(2H)-yl)oxy)methyl dihydrogen phosphate;Fosciclopirox, 10 mM in DMSO
CAS:1380539-06-9
MF:C13H20NO6P
MW:317.27
EINECS:
Product Categories:
Mol File:1380539-06-9.mol
Fosciclopirox Structure
Fosciclopirox Chemical Properties
Boiling point 484.8±55.0 °C(Predicted)
density 1.38±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 100 mg/mL (315.19 mM; Need ultrasonic)
pka1.68±0.10(Predicted)
form Solid
color Off-white to light yellow
Safety Information
MSDS Information
Fosciclopirox Usage And Synthesis
UsesFosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract[1][2]. Ciclopirox has anticancer activity in a number of solid and hematologic malignancies.
References[1] Weir SJ, et al. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex. Cell Death Dis. 2021 May 31;12(6):562. DOI:10.1038/s41419-021-03836-z
[2] Weir SJ, Wood R, Schorno K, Brinker AE, Ramamoorthy P, Heppert K, Rajewski L, Tanol M, Ham T, McKenna MJ, McCulloch W, Dalton M, Reed GA, Jensen RA, Baltezor MJ, Anant S, Taylor JA 3rd. Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs. J Pharmacol Exp Ther. 2019 Aug;370(2):148-159. DOI:10.1124/jpet.119.257972
Fosciclopirox Preparation Products And Raw materials
Tag:Fosciclopirox(1380539-06-9) Related Product Information
Fosciclopirox 2(1H)-Pyridinone, 6-cyclohexyl-4-methyl-1-[(phosphonooxy)methoxy]-, sodium salt (1:2) cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid MRK 560 Anti-Aging Compound Library 2H-1,2,4-Oxadiazine, 5-(4-chlorophenyl)-6-cyclopropyl-5,6-dihydro-3-[6-methoxy-5-(4-methyl-1H-imidazol-1-yl)-2-pyridinyl]-, (5R,6S)-rel-(+)-